AJ, V., MC, M., SK, M., ME, T., JM, A., EP, H., & BD, M. (2020). IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex. JCI insight, 5(7), . https://doi.org/10.1172/jci.insight.135071
Chicago Style (17th ed.) CitationAJ, Valvezan, McNamara MC, Miller SK, Torrence ME, Asara JM, Henske EP, and Manning BD. "IMPDH Inhibitors for Antitumor Therapy in Tuberous Sclerosis Complex." JCI Insight 5, no. 7 (2020). https://doi.org/10.1172/jci.insight.135071.
MLA (9th ed.) CitationAJ, Valvezan, et al. "IMPDH Inhibitors for Antitumor Therapy in Tuberous Sclerosis Complex." JCI Insight, vol. 5, no. 7, 2020, https://doi.org/10.1172/jci.insight.135071.
Warning: These citations may not always be 100% accurate.